show episodes
 
Loading …
show series
 
We discuss cardiogenic shock and decision making in the case of a young female presenting to the ER. We have a panel of cardiologists guide the discussion. Drs Rene Alvarez, Daniel Sims and Alec Vishnevski discuss the case presented by cardiology fellow Rachna Kataria, MD. Thanks for listening. Please like, subscribe and give us a rating.…
 
We discuss the various aspects of cardiogenic shock including definition, heterogeneity, classification and management with an internationally renowned expert in the field Dr Navin Kapur. Dr Kapur is the Director of the Acute Mechanical Circulatory Support Program at Tufts University School of Medicine, Boston, MA. Listen, like, subscribe, and give…
 
We discuss several aspects of cardio-oncology including screening protocols, specific chemotherapy related cardiotoxicities and management of cardiovascular disease among cancer patients and cancer survivors. Dr Sherry-Ann Brown is the director of Cardio-Oncology at the Medical College of Wisconsin, Milwaukee, WI. Listen, like, subscribe, and give …
 
We discuss several aspects of cardiac arrhythmias and their management among cancer patients and cancer survivors with Drs Fradley and Guha. Dr Fradley is an electrophysiologist and Dr Guha is a non-invasive cardiologist, both with tremendous expertise in cardio-oncology. Dr Fradley is the Medical Director of Cardio-Oncology at University of Pennsy…
 
We discuss some radiation physics, role for ionizing radiation in treating cancer & related cardiac damage with Dr Brett Lewis MD PhD. Dr. Lewis has interest & expertise in treating several thoracic malignancies & practices at Hackensack Meridian Health, NJ. Listen, like, subscribe, and give us a high rating.…
 
We discuss several classes of cancer therapies including chemotherapy, immunotherapy, CAR T-Cell therapies and related cardiovascular toxicity from the perspective of a board certified oncologist Dr Kaushal Parikh, MD. Dr Parikh specializes in thoracic oncology and practices at Hackensack Meridian Health, NJ. Listen, Like, Subscribe, and give us a …
 
We review the inpatient management in HFrEF, role of GDMT initiation & HF exacerbating drugs. We end the episode with a discussion on HFpEF & device therapies with Professor Carolyn Lam, a Senior Consultant of the National Heart Centre, Singapore and Professor of Duke-NUS Cardiovascular Academic Clinical Program. Listen, Like, Subscribe, and give u…
 
Jane Ferguson: Hi there. Welcome to Getting Personal: Omics of the Heart, the podcast from Circulation: Genomic and Precision Medicine. I'm Jane Ferguson, and this is Episode 36 from February 2020. First up, we have “Identification of Circulating Proteins Associated with Blood Pressure Using Mendelian Randomization” from Sébastien Thériault, Guilla…
 
Jane Ferguson: Hi, everyone. Welcome to episode 35 of Getting Personal: Omics of the Heart, the podcast from Circulation: Genomic and Precision Medicine. I'm Jane Ferguson, an assistant professor of medicine at Vanderbilt University Medical Center, and an associate editor at Circulation: Genomic and Precision Medicine. This episode is first airing …
 
We discuss Coronavirus Disease 2019 and cardiovascular involvement. Dr Jennifer Haythe, a Heart Failure cardiologist from Columbia University Medical Center talks about the cardiovascular sequelae associated with COVID-19 and related management. We end with HCW protection, appropriate PPE, new data of HCQ and investigational therapies. Listen, Like…
 
We discuss Coronavirus Disease 2019 in the USA. Dr Udit Chaddha, a Pulmonary Disease & Critical Care specialist from the Icahn School of Medicine - Mount Sinai Hospital in New York talks about the virus, disease identification, healthcare worker protection and management of related acute respiratory illness. Listen, Like, Subscribe, and give us a r…
 
We discuss transthyretin (aTTR) cardiac amyloidosis, symptoms, appropriate diagnostic testing and different treatment options available. Dr. Mathew Maurer from NewYork-Presbyterian Hospital/Columbia University shares his expertise with us. Listen, Like, Subscribe, and give us a rating!By Mahek Shah, MD
 
Management of light chain or AL amyloidosis has changed with major advances in recent years. Dr. Ronald Witteles is a Stanford Cardiologist with particular expertise in the treatment of cardiac amyloidosis and shares his expertise with us. He serves as Co-Director of the Stanford Amyloid Center, one of the world's leading amyloid centers. Listen, L…
 
Sudden cardiac death in heart failure has changed as therapies have evolved. We discuss arrhythmic and non arrhythmic sudden death in heart failure, and how we can lower its incidence. Dr Nasrien Ibrahim MD from Massachusetts General Hospital affiliated with Harvard Medical School shares her expertise. Listen, Like, Subscribe, and give us a rating!…
 
Diabetes management is evolving and we discuss the role of cardiologists in improving cardio-metabolic care. Dr Muthiah Vaduganathan MD MPH from Brigham and Women's Hospital & Harvard Medical School shares his expertise on the evidence for newer drugs and how cardiologists can get engaged in diabetes management. This is episode three of four in our…
 
Jane Ferguson: Hi there. Welcome to the November 2019 issue of Getting Personal: Omics of the Heart. I'm Jane Ferguson. This is your podcast from Circulation: Genomic and Precision Medicine. Let's get started. First up from Eric Curruth, Christopher Haggerty and colleagues from Geisinger, we have a paper entitled, “Prevalence and Electronic Health …
 
Diabetes management is changing rapidly, and with that we have newer management strategies with cardiovascular benefit. Dr Ritika Puri shares an endocrinologist's perspective on where diabetes stands today, and shares interesting insights into how to approach cardiovascular disease in diabetes management. This is episode two of four in our Diabeto-…
 
Ilya Danelich PharmD (Board Certified Cardiac Pharmacist) walks us through the mechanism of action and pearls for different classes of diabetic drugs including the NEWER drugs. We also describe how to prescribe the newer SGLT2 inhibitors and review mechanisms for adverse effects and cardiovascular/renal benefits. This is episode one of four in our …
 
We introduce you to our new HeartSuccess team member. Our episode includes two TCT 2019 trials (EXCEL, TWILIGHT), the Polypill study, Role of Beta Blockers in HFpEF, Use of lung zone US in HF in predicting outcomes, Hemodynamics of lung congestion in HFpEF, CITRIS-ALI study, Hypothermia in non-shockable rhythm cardiac arrest and 20-Year Follow-up o…
 
Jane Ferguson: Hello. Welcome to episode 33 of Getting Personal: Omics Of The Heart, your podcast from Circulation: Genomic and Precision Medicine. I'm Jane Ferguson. This episode is from October 2019. Let's get started. First up is a paper from Sébastien Thériault, Yohan Bossé, Jean-Jacques Schott and colleagues from Laval University, Quebec and I…
 
Jane Ferguson: Hi, everyone. Welcome to Getting Personal: Omics of the Heart, the monthly podcast from Circulation: Genomic and Precision Medicine. I'm Jane Ferguson, an assistant professor of medicine at Vanderbilt University Medical Center and an associate editor at CircGen. This is episode 32 from September 2019. Starting off this month, we have…
 
The European Society of Cardiology is one of the largest annual cardiology meetings. Here we summarize all the important trials that were presented at this meeting and discuss their impact on clinical practice. Listen, Like, Subscribe and don't forget to give us a Rating!!By Mahek Shah, MD
 
Jane Ferguson: Hello, and welcome to Getting Personal, Omics of the Heart, your monthly podcast from Circulation: Genomic and Precision Medicine. I'm Jane Ferguson. It is August, 2019, and this is episode 31. Let's get started. Our first paper comes from Freyja van Lint and Cynthia James, from University Medical Center Utrecht, and is entitled Arrh…
 
Dr Janani Rangaswami is a leading expert in the field of Cardiorenal syndrome. We get into a great discussion on understanding Cardiorenal syndrome, its underlying pathophysiology, approach to the disease, several clinical tidbits and how to manage such patients based on contemporary data. Dr Rangaswami recently led the 2019 Scientific Statement Fr…
 
Dr Scott Hummel from the University of Michigan walks us through the evidence for and against sodium restriction in heart failure. He discusses his approach backed by his research on the role of diet and nutrition in heart failure. We also discuss some of the latest research where there may be a role for using hypertonic saline and chloride in cert…
 
Loading …

Quick Reference Guide

Copyright 2020 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login